Flurashield Chewables for Dogs (2 to 4.5Kg)

Flurashield Chewable Tablet represents an advance solution for the treatment and management of mange, mites, flea and tick infestations, offering an impressive 90-day efficacy period following a single administration.  This meticulously formulate tablet contains fluralaner, and active compound classified within the esteemed antiparasitic isoxazoline-substituted benzamide derivatives family. Flurashield Chewable Tablets display remarkable efficacy against strains of fleas that demonstrate resistance to fipronil, establishing its prowess in addressing evolving parasitic challenges.

Flurashield Chewable Tablets deliver a dual-action approach, effectively eradicating both ticks and fleas, contributing to a holistic relief from ectoparasitic burdens.

Precautions

Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders.

Adverse events have been reported following use in breeding females. Before use in breeding female dogs, refer to Post-Approval Experience and Animal Safety sections.

Flurashield has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Flurashield is not effective against Amblyomma americanum ticks beyond 8 weeks after dosing